Scynexis (SCYX) Other Working Capital Changes (2013 - 2026)
Scynexis (SCYX) reported Other Working Capital Changes of $816000.0 for Q1 2026, up 206.67% on a YoY basis from $266087.0 in Q1 2025, and up 134.92% quarter-over-quarter from -$2.3 million in Q4 2025.
Scynexis (SCYX) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Scynexis has reported Other Working Capital Changes for 14 years, with the latest figure at $816000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 206.67% year-over-year to $816000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.1 million (down 9.69% YoY), and the FY2025 full-year result was -$2.7 million, down 176.0% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $816000.0, up from -$2.3 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $4.4 million in Q2 2023, with the low at -$3.7 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$95625.0 across 5 years, with a median of -$93000.0 in 2024.
- The largest YoY upside for Other Working Capital Changes was 611.59% in 2023 against a maximum downside of 92425.0% in 2023.
- Scynexis' Other Working Capital Changes stood at -$2.2 million in 2022, then surged by 204.35% to $2.3 million in 2023, then surged by 32.57% to $3.1 million in 2024, then tumbled by 176.55% to -$2.3 million in 2025, then soared by 134.92% to $816000.0 in 2026.
- The last three Other Working Capital Changes figures came in at $816000.0 (Q1 2026), -$2.3 million (Q4 2025), and $438000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Scynexis | 225.23 Mn | 165.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 816,000.00 |
| Mar 31, 2026 | 816,000.00 |
| Dec 31, 2025 | -2.34 Mn |
| Dec 31, 2025 | -2.34 Mn |
| Sep 30, 2025 | 438,000.00 |
| Sep 30, 2025 | 438,000.00 |
| Jun 30, 2025 | -38,000.00 |
| Jun 30, 2025 | -38,000.00 |
| Mar 31, 2025 | -765,000.00 |
| Mar 31, 2025 | -765,000.00 |
| Dec 31, 2024 | 3.05 Mn |
| Dec 31, 2024 | 3.05 Mn |
| Sep 30, 2024 | -3.16 Mn |
| Sep 30, 2024 | -3.16 Mn |
| Jun 30, 2024 | -148,000.00 |
| Jun 30, 2024 | -148,000.00 |
| Mar 31, 2024 | -722,000.00 |
| Mar 31, 2024 | -722,000.00 |
| Dec 31, 2023 | 2.30 Mn |
| Dec 31, 2023 | 2.30 Mn |